- Home
- SKBL vs BME Comparison
SKBL vs BME Comparison
Compare SKBL & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKBL
- BME
- Stock Information
- Founded
- SKBL 2012
- BME 2005
- Country
- SKBL Hong Kong
- BME United States
- Employees
- SKBL N/A
- BME N/A
- Industry
- SKBL
- BME Trusts Except Educational Religious and Charitable
- Sector
- SKBL
- BME Finance
- Exchange
- SKBL NYSE
- BME Nasdaq
- Market Cap
- SKBL 389.6M
- BME 462.3M
- IPO Year
- SKBL 2025
- BME N/A
- Fundamental
- Price
- SKBL $12.35
- BME $36.12
- Analyst Decision
- SKBL
- BME
- Analyst Count
- SKBL 0
- BME 0
- Target Price
- SKBL N/A
- BME N/A
- AVG Volume (30 Days)
- SKBL 745.6K
- BME 34.0K
- Earning Date
- SKBL 01-01-0001
- BME 01-01-0001
- Dividend Yield
- SKBL N/A
- BME 6.26%
- EPS Growth
- SKBL N/A
- BME N/A
- EPS
- SKBL 0.03
- BME 1.44
- Revenue
- SKBL $49,638,709.00
- BME N/A
- Revenue This Year
- SKBL N/A
- BME N/A
- Revenue Next Year
- SKBL N/A
- BME N/A
- P/E Ratio
- SKBL $393.54
- BME $28.37
- Revenue Growth
- SKBL 9.58
- BME N/A
- 52 Week Low
- SKBL $6.93
- BME $35.53
- 52 Week High
- SKBL $13.50
- BME $43.20
- Technical
- Relative Strength Index (RSI)
- SKBL N/A
- BME 41.49
- Support Level
- SKBL N/A
- BME $36.09
- Resistance Level
- SKBL N/A
- BME $37.65
- Average True Range (ATR)
- SKBL 0.00
- BME 0.50
- MACD
- SKBL 0.00
- BME 0.05
- Stochastic Oscillator
- SKBL 0.00
- BME 26.44
About SKBL SKYLINE BUILDERS GROUP HOLDING LIMI
Skyline Builders Group Holding Ltd is an holding company operates through its subsidiary. It is a Public Works Contractor company undertaking roads and drainage in Hong Kong. Its construction activities mainly include public civil engineering works, such as road and drainage works, in Hong Kong.
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.